Cargando…
Nanoparticles to Improve the Efficacy of Peptide-Based Cancer Vaccines
Nanoparticles represent a potent antigen presentation and delivery system to elicit an optimal immune response by effector cells targeting tumor-associated antigens expressed by cancer cells. Many types of nanoparticles have been developed, such as polymeric complexes, liposomes, micelles and protei...
Autores principales: | Tornesello, Anna Lucia, Tagliamonte, Maria, Tornesello, Maria Lina, Buonaguro, Franco M., Buonaguro, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226445/ https://www.ncbi.nlm.nih.gov/pubmed/32340356 http://dx.doi.org/10.3390/cancers12041049 |
Ejemplares similares
-
Virus-like Particles as Preventive and Therapeutic Cancer Vaccines
por: Tornesello, Anna Lucia, et al.
Publicado: (2022) -
New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology
por: Tornesello, Anna Lucia, et al.
Publicado: (2017) -
Antimicrobial Peptides as Anticancer Agents: Functional Properties and Biological Activities
por: Tornesello, Anna Lucia, et al.
Publicado: (2020) -
Systems Biology Approach for Cancer Vaccine Development and Evaluation
por: Circelli, Luisa, et al.
Publicado: (2015) -
Genetic and phylogenetic evolution of HIV-1 in a low subtype heterogeneity epidemic: the Italian example
por: Buonaguro, Luigi, et al.
Publicado: (2007)